Evidence-based medicine

Fourth Chinese Physicians Assembly for Humanity Launches First International Section on Evidence-based Medicine, Calls for Global Collaboration

Retrieved on: 
Tuesday, November 15, 2022

BEIJING, Nov. 15, 2022 /PRNewswire/ -- The Fourth Chinese Physicians Assembly for Humanity (CPAH) launched its first international section, inviting experts, doctors, and public welfare professionals from the United Kingdom, Norway, the Czech Republic, and other countries to share their insights on evidence-based medicine (EBM).

Key Points: 
  • BEIJING, Nov. 15, 2022 /PRNewswire/ -- The Fourth Chinese Physicians Assembly for Humanity (CPAH) launched its first international section, inviting experts, doctors, and public welfare professionals from the United Kingdom, Norway, the Czech Republic, and other countries to share their insights on evidence-based medicine (EBM).
  • This year's CPAH was held both online and offline on November 4-5, with the theme of Cohesion and Co-Construction: the Responsibilities of Physicians on Health-Care Welfare.
  • The online international section garnered over one million viewers worldwide.
  • The assembly advocated for a spirit of bravery and endeavors to unite public welfare physicians and healthcare enterprises to collaboratively build a new Great Wall of Health and Public Welfare.

United States Teleradiology Industry to 2027 - Advances in Digital Diagnostic Imaging Technologies Presents Opportunties

Retrieved on: 
Friday, November 11, 2022

Through teleradiology, images can be sent to other parts of the hospital or locations across a country or world.

Key Points: 
  • Through teleradiology, images can be sent to other parts of the hospital or locations across a country or world.
  • Teleradiology is a field of telemedicine in which telecommunication systems are used to transmit radiological images from one location to another.
  • The earliest effort in teleradiology probably dates to 1929, when dental X-rays were transmitted over telegraph to a distant location.
  • Compressed digital imaging tools and picture archiving & communication systems (PACS) have helped physicians make teleradiology more accessible and feasible.

THE AESTHETIC SOCIETY & THE AESTHETIC SURGERY EDUCATION AND RESEARCH FOUNDATION UNVEILS FINDINGS FROM THE BIOSPECIMEN STUDY ON BREAST IMPLANT ILLNESS (BII)

Retrieved on: 
Wednesday, November 9, 2022

GARDEN GROVE, Calif., Nov. 9, 2022 /PRNewswire/ -- The Aesthetic Society and The Aesthetic Surgery Education and Research Foundation (ASERF) today released the findings from a study dedicated to researching the systemic symptoms self-reported by some breast implant patients, known as Breast Implant Illness. The Aesthetic Society is recognized as the world's leading member organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body with 2,600 board-certified plastic surgeons in membership. ASERF is the philanthropic research and education arm of The Aesthetic Society. This study was funded entirely by an Aesthetic Surgery Education and Research Foundation (ASERF) grant awarded in 2019. There was no outside sponsor involvement in the research, data collection, data interpretation, data analysis, or writing of the manuscript. The full study is published in a peer-reviewed medical journal, the Aesthetic Surgery Journal.

Key Points: 
  • GARDEN GROVE, Calif., Nov. 9, 2022 /PRNewswire/ -- The Aesthetic Society and The Aesthetic Surgery Education and Research Foundation (ASERF) today released the findings from a study dedicated to researching the systemic symptoms self-reported by some breast implant patients, known as Breast Implant Illness.
  • This study was funded entirely by an Aesthetic Surgery Education and Research Foundation (ASERF) grant awarded in 2019.
  • The Aesthetic Society is at the forefront of innovation in aesthetic plastic surgery and cosmetic medicine globally.
  • Visit our website: www.theaestheticsociety.org
    The Aesthetic Surgery Education and Research Foundation (ASERF) is a 501(c)(3) not-for-profit charitable foundation.

ECRI Names Monument Health Winner of 2022 Safety Excellence Award

Retrieved on: 
Monday, November 7, 2022

PLYMOUTH MEETING, Pa., Nov. 7, 2022 /PRNewswire/ -- ECRI, the nation's largest nonprofit patient safety organization, names Monument Health of Rapid City, SD, winner of the 2022 Safety Excellence Award. Monument Health is recognized for exceeding organization-wide safety goals of reducing harm and errors by improving culture of safety and event reporting.

Key Points: 
  • Bestowed by the joint ECRI and Institute for Safe Medication Practices PSO, the award lauds the South Dakota health system for improving culture of safety
    PLYMOUTH MEETING, Pa., Nov. 7, 2022 /PRNewswire/ --ECRI, the nation's largest nonprofit patient safety organization, names Monument Health of Rapid City, SD, winner of the 2022 Safety Excellence Award.
  • The Safety Excellence Award recognizes a member of the joint ECRI and the Institute for Safe Medication Practices (ISMP) PSO for outstanding patient safety efforts and initiatives.
  • "We applaud Monument Health for advancing patient safety through increased reporting and other process improvements," says Dheerendra Kommala, MD, chief medical officer, ECRI.
  • The 2022 Safety Excellence Award ceremony took place at the ECRI and the ISMP PSO's Annual Meeting, held virtually on November 2, 2022.

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

Retrieved on: 
Monday, October 31, 2022

DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market opens on Tuesday, November 8, 2022.

Key Points: 
  • DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market opens on Tuesday, November 8, 2022.
  • The Companys management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
  • To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Evidation Launches FluSmart, A Direct-to-Person Digital Flu Monitoring Program, To Better Understand Flu in Everyday Life

Retrieved on: 
Wednesday, October 26, 2022

Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.

Key Points: 
  • Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.
  • View the full release here: https://www.businesswire.com/news/home/20221026005641/en/
    Evidations FluSmart is a nationwide program that helps people proactively understand risk factors for flu and provides personalized insights related to flu and influenza-like illness.
  • Individuals can report flu symptoms at any time and do not need a wearable to participate in the program.
  • Evidation has developed machine learning detection models to compare flu and COVID and validated and extended this work with collaborators .

Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

Retrieved on: 
Thursday, October 20, 2022

The combined company addresses the full cancer care continuum, and is working to create an oncology ecosystem to support care providers along the entire cancer care journey from screening to survivorship.

Key Points: 
  • The combined company addresses the full cancer care continuum, and is working to create an oncology ecosystem to support care providers along the entire cancer care journey from screening to survivorship.
  • The innovative products, technologies, and clinical research Varian will feature during this year's show reflect the company's evolution into a comprehensive cancer care company and commitment to helping care providers make more informed decisions at every point of the cancer care journey.
  • Connected Imaging: As a Siemens Healthineers company, Varian is enabling greater personalization of cancer care through multimodality imaging and connecting oncology teams with advanced imaging capabilities inside and outside the treatment vault.
  • With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago   

Retrieved on: 
Wednesday, October 12, 2022

The BoneScalpel Access handpiece 20 mm blade and Micro Hook Shaver will be available throughout the U.S. on October 17.

Key Points: 
  • The BoneScalpel Access handpiece 20 mm blade and Micro Hook Shaver will be available throughout the U.S. on October 17.
  • The BoneScalpel Access handpiece allows surgeons to leverage the many advantages of ultrasonic bone cutting in minimally invasive spinal procedures.
  • Combined with OSTEOAMP Flowable, Bioventus now has a full portfolio for MIS spine procedures, the fastest growing segment of spine surgery.
  • The Bioventus surgical solutions portfolio brings together innovative products that add value for surgical applications in decompression and fusion.

Breaking Data on the Efficacy and Cost-Effectiveness of an Exclusive Human Milk Diet for Premature Infants To Be Presented at the American Academy of Pediatrics 2022 National Conference

Retrieved on: 
Friday, October 7, 2022

One study based on real-world data from seven U.S. hospitalsdemonstrates the efficacy and cost-effectiveness of an EHMD for premature infants.

Key Points: 
  • One study based on real-world data from seven U.S. hospitalsdemonstrates the efficacy and cost-effectiveness of an EHMD for premature infants.
  • "These collaborative data fill gaps in evidence-based medicine for NICU leaders and provide support for implementing an EHMD for very preterm infants," Dr. Fox said.
  • The major difference between cow milk-based and human milk-based products is the composition notably, the bioactive components that are unique to human milk.
  • Prolacta maintains the industry's strictest quality and safety standards for screening, testing, and processing donor human milk.

WETHRIVV® LLC Expands Maskād® Products to Include Direct-to-Consumer

Retrieved on: 
Monday, October 3, 2022

DOYLESTOWN, Pa., Oct. 3, 2022 /PRNewswire/ -- Amy and Sanjay Batra are excited to launch their Maskād® consumer line. Using the same science-based and clean-ingredient approach as Maskād Pro Series, they created a system that includes a derma roller, growth factor and peptide serum, hyaluronic acid serum and face mask.

Key Points: 
  • DOYLESTOWN, Pa., Oct. 3, 2022 /PRNewswire/ --Amy and Sanjay Batra are excited to launch their Maskd consumer line.
  • It is a pleasure to collaborate with them and support the science and research of the Maskd product portfolio".
  • Controlled clinical studies have shown that products containing growth factors:
    The Maskd Hydrating Serum is clean and simple - comprised of only 3 ingredients and available in 2 sizes.
  • WETHRIVV LLC is methodically creating a portfolio of professional and consumer products poised to elevate customer experience and satisfaction in facial aesthetics and hair growth markets.